PRF Technologies (PRFX) Notes Payables (2019 - 2025)

PRF Technologies (PRFX) posted quarterly Notes Payables of $50000.0 for Q2 2025, down 99.06% on a QoQ basis from $5.3 million in Q2 2020.

PRF Technologies (PRFX) Notes Payables (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Notes Payables for 3 consecutive years, with $50000.0 the latest figure, recorded in Q2 2025.

Quarterly Notes Payables changed N/A year-over-year to $50000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $50000.0 (changed N/A YoY) and the FY2019 annual result came in at $5.1 million, changed N/A from the prior year.
Notes Payables eased to $50000.0 in Q2 2025 per PRFX's latest filing, from $5.3 million in the prior quarter.
Over the last five years, Notes Payables for PRFX reached as high as $50000.0 in Q2 2025 and fell as low as $50000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	PRF Technologies	745,168.93	451,168.93	-

Download Data